ATE442865T1 - Dreigeteilte konjugate mit einer struktur, die mit zellmembran-rafts interagieren und ihre verwendung - Google Patents

Dreigeteilte konjugate mit einer struktur, die mit zellmembran-rafts interagieren und ihre verwendung

Info

Publication number
ATE442865T1
ATE442865T1 AT05732179T AT05732179T ATE442865T1 AT E442865 T1 ATE442865 T1 AT E442865T1 AT 05732179 T AT05732179 T AT 05732179T AT 05732179 T AT05732179 T AT 05732179T AT E442865 T1 ATE442865 T1 AT E442865T1
Authority
AT
Austria
Prior art keywords
moiety
cell membrane
membrane rafts
structure interacting
part conjugates
Prior art date
Application number
AT05732179T
Other languages
English (en)
Inventor
Tobias Braxmeier
Tim Friedrichson
Wolfgang Froehner
Gary Jennings
Michael Munick
Georg Schlechtingen
Cornelia Schroeder
Hans-Joachim Knoelker
Kai Simons
Marino Zerial
Teymuras Kurzchalia
Original Assignee
Jado Technologies Gmbh
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jado Technologies Gmbh, Max Planck Gesellschaft filed Critical Jado Technologies Gmbh
Application granted granted Critical
Publication of ATE442865T1 publication Critical patent/ATE442865T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AT05732179T 2004-04-08 2005-04-08 Dreigeteilte konjugate mit einer struktur, die mit zellmembran-rafts interagieren und ihre verwendung ATE442865T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04008607 2004-04-08
US57506804P 2004-05-27 2004-05-27
US66197605P 2005-03-11 2005-03-11
PCT/EP2005/003740 WO2005097199A1 (en) 2004-04-08 2005-04-08 Tripartite conjugates containing a structure interacting with cell membrane rafts and their use

Publications (1)

Publication Number Publication Date
ATE442865T1 true ATE442865T1 (de) 2009-10-15

Family

ID=34965861

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05732179T ATE442865T1 (de) 2004-04-08 2005-04-08 Dreigeteilte konjugate mit einer struktur, die mit zellmembran-rafts interagieren und ihre verwendung

Country Status (7)

Country Link
US (1) US20080317767A1 (de)
EP (2) EP1732612B1 (de)
AT (1) ATE442865T1 (de)
AU (1) AU2005231622B2 (de)
CA (1) CA2562266A1 (de)
DE (1) DE602005016658D1 (de)
WO (1) WO2005097199A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2660120C (en) * 2006-08-04 2016-04-05 Snow Brand Milk Products Co., Ltd. Agent for preventing infection
JP5202827B2 (ja) * 2006-08-04 2013-06-05 雪印メグミルク株式会社 感染予防剤
AU2008238379A1 (en) 2007-04-13 2008-10-23 Sanofi-Aventis A transition metal catalyzed synthesis of N-aminoindoles
GB0720503D0 (en) * 2007-10-22 2007-11-28 Angeletti P Ist Richerche Bio New compound
WO2010078329A1 (en) * 2008-12-30 2010-07-08 President And Fellows Of Harvard College Methods and compositions for the treatment of pathogenic diseases
WO2013150532A1 (en) * 2012-04-04 2013-10-10 Yeda Research And Development Co. Ltd. Lipopeptide conjugates comprising sphingolipid and hiv gp41 derived peptides
JP2017505778A (ja) * 2014-01-29 2017-02-23 ヒューメディックス カンパニー,リミテッド ペグ化7−デヒドロコレステロール誘導体
WO2016083426A1 (en) * 2014-11-28 2016-06-02 F. Hoffmann-La Roche Ag Peptides
JP6691914B2 (ja) * 2014-11-28 2020-05-13 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ペプチド
HK1251593A1 (zh) * 2015-07-24 2019-02-01 豪夫迈‧罗氏有限公司 Bace1抑制剂肽
EA201891472A1 (ru) * 2015-12-22 2018-12-28 Такеда Фармасьютикал Компани Лимитед Тройные модуляторы эндосомальных рецепторов, сопряженных с g-белком
WO2017197463A1 (en) * 2016-05-20 2017-11-23 Monash University Treatment of pain
CA3080521A1 (en) 2017-10-27 2019-05-02 Children's Medical Center Corporation Short chain ceramide-based lipids and uses thereof
EP3727386A1 (de) * 2017-12-20 2020-10-28 Takeda Pharmaceutical Company Limited Inhibitoren des protease-aktivierten rezeptors-2
EP3773564A4 (de) * 2018-04-12 2022-04-20 Children's Medical Center Corporation Ceramid-ähnliche lipdbasierte freisetzungsvehikel und deren verwendung
BR112021010125A2 (pt) * 2018-11-26 2021-08-24 Arytha Biosciences Llc Nanopartículas que contêm membrana celular e usos das mesmas
US20240066027A1 (en) 2020-12-03 2024-02-29 Domain Therapeutics Novel par-2 inhibitors
KR102423002B1 (ko) * 2021-02-17 2022-07-21 주식회사 엘씨에스바이오텍 신규 세라마이드, 그의 제조방법 및 그의 용도
EP4532496A1 (de) 2022-06-03 2025-04-09 Domain Therapeutics Par-2-inhibitoren
WO2025191185A1 (en) 2024-03-15 2025-09-18 Domain Therapeutics Azine-based compounds as par-2 inhibitors and therapeutic uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5446026A (en) * 1989-08-09 1995-08-29 Advanced Peptides & Biotechnology Sciences Potent non-opiate analgesic
IT1234909B (it) * 1989-09-11 1992-06-02 Farina Attilio Dispositivo di telecomando per ricevitore di televisione atto a cifrare in modo esclusivo i codici di comando e corrispondente circuito decifratore
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
US5439899A (en) * 1993-03-10 1995-08-08 Purdue Research Foundation Cosalane and related compounds having activity against aids and aids-related infections
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
GB2355009A (en) * 1999-07-30 2001-04-11 Univ Glasgow Peptides conjugated to bile acids/salts
US7122533B2 (en) * 1999-11-29 2006-10-17 The United States Of America As Represented By The Department Of Health And Human Services Cosalane compounds and methods for their use
US6562805B1 (en) * 1999-11-29 2003-05-13 Purdue Research Foundation Cosalane compounds and methods for their use

Also Published As

Publication number Publication date
EP1732612B1 (de) 2009-09-16
AU2005231622A1 (en) 2005-10-20
AU2005231622B2 (en) 2011-05-26
EP1732612A1 (de) 2006-12-20
WO2005097199A1 (en) 2005-10-20
DE602005016658D1 (de) 2009-10-29
CA2562266A1 (en) 2005-10-20
EP2119455A1 (de) 2009-11-18
US20080317767A1 (en) 2008-12-25

Similar Documents

Publication Publication Date Title
DE602005016658D1 (de) Dreigeteilte konjugate mit einer struktur, die mit zellmembran-rafts interagieren und ihre verwendung
ATE478685T1 (de) Prodrugs mit neuen biospaltbaren verbindern
DE502007005648D1 (de) Tripentylcitrate und deren Verwendung als Weichmacher
DE60234164D1 (de) Neues a-liponsäurederivat und dessen verwendung
ECSP045381A (es) Polipéptidos y rutas biosintéticas
EP1930455A4 (de) Nickelbasis-superlegierung mit hervorragender oxidationsunempfindlichkeit
WO2006060314A3 (en) Generation of replication competent viruses for therapeutic use
EP1834570A4 (de) Eingeführter teil für endoskope
MY143249A (en) 4-substituted pyrrolidin-2-ones and their use
EP1970119A4 (de) Katalysatorzusammensetzung für die insertion von kohlendioxid in organische verbindungen
FR2872504B1 (fr) Purification de l'acide chlorhydrique sous-produit de la synthese de l'acide methane sulfonique
ITMO20060039A1 (it) Ponte a campata unica, anche di grandissima luce, ad arco a via inferiore, idoneo al transito dei treni piu' pesanti, totalmente isolato sismicamente, insensibile alla liquefazione del terreno, non soggetto ad instabilita' aeroelastica, suscettibile
EP2057139A4 (de) Schwefelwasserstoffderivate von nicht-steroidalen antiinflammatorisch-wirkenden medikamenten
EP1746141A4 (de) Verdickungsmittel
EP2140934A4 (de) Katalysatormaterial zur erzeugung von sauerstoffgas aus wasser
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
EP1776863A4 (de) Agrarchemikalienzusammensetzung
JP2007182567A5 (de)
BR0010980A (pt) Naftopiranos anelados em c5-c6, com um anel c6 tipo lactama, e composições e (co) polìmeros contendo-os
PT1435235E (pt) Utilizacao de acido hidroxioleico e compostos semelhantes na producao de medicamentos
WO2008117871A1 (ja) 含窒素レドックス触媒
ATE452877T1 (de) Herstellung von 3-(alkylthio)propanal
ATE453658T1 (de) Konjugate mit entzündungshemmender aktivität
WO2007002722A3 (en) Synthesis of anastrozole and purification of one of its intermediate
DE602005019703D1 (de) Polymorphe von atorvastatin-tert.-butylester und deren verwendung als zwischenprodukte für die herstellung von atorvastatin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties